Followers | 27 |
Posts | 3592 |
Boards Moderated | 0 |
Alias Born | 08/16/2013 |
Thursday, August 02, 2018 10:11:34 AM
RGBP already had some toxic funding. Massive dilution for RGBP happened as result of this (RGBP once started with only 50M shares autorized)
Meanwhile HemaX since 3 years is collecting dust on the shelve and still no money for Phase 1 trials and worst than that ... there's no intention for anything related to HemaX or DcellVax.
Because history repeats itself i would place my bets rather on more toxic funding and massive dilution than on any sustainable outcome from RGBP
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM